|Articles|October 12, 2020
Patient Support Programs: Considerations for Crisis Management and Risk Mitigation
Author(s)Covance
This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Eli Lilly’s and Novo’s Stocks React to President Trump’s Comments on GLP-1 Prices
2
EMD Serono Announces Agreement with Trump Administration Increasing Access to In Vitro Fertilization Therapies for US Patients
3
All of the Medications Announced as Part of FDA’s National Priority Voucher Program
4
Autonomous Omnichannel: When AI Thinks for Pharma Marketing
5
